Does LENVATINIB Cause Cholecystitis? 309 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 309 reports of Cholecystitis have been filed in association with LENVATINIB (Lenvima). This represents 0.9% of all adverse event reports for LENVATINIB.
309
Reports of Cholecystitis with LENVATINIB
0.9%
of all LENVATINIB reports
11
Deaths
261
Hospitalizations
How Dangerous Is Cholecystitis From LENVATINIB?
Of the 309 reports, 11 (3.6%) resulted in death, 261 (84.5%) required hospitalization, and 6 (1.9%) were considered life-threatening.
Is Cholecystitis Listed in the Official Label?
Yes, Cholecystitis is listed as a known adverse reaction in the official FDA drug label for LENVATINIB.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Cholecystitis?
SEMAGLUTIDE (293)
PEMBROLIZUMAB (245)
ADALIMUMAB (234)
METHOTREXATE (205)
NIVOLUMAB (183)
RITUXIMAB (159)
LENALIDOMIDE (144)
BEVACIZUMAB (131)
CYCLOPHOSPHAMIDE (131)
DEXAMETHASONE (126)
Which LENVATINIB Alternatives Have Lower Cholecystitis Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE